期刊文献+

骨髓移植后淋巴组织增生性疾病附二例报告

原文传递
导出
摘要 移植后淋巴组织增生性疾病(PTLD)是个体在接受异体的实质性器官或骨髓移植后引起机体免疫抑制继而发生的一种罕见的并发症,其发生率因移植的器官类型和免疫抑制剂的应用情况不同而异,发生在骨髓移植后的PTLD罕见,约为1%。现将我院确诊的2例PTLD分析如下,并结合文献讨论其临床病理特征。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第2期125-126,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献9

  • 1Lim GY, Newman B, Kurland G, et al. Post transplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients. Radiology, 2002, 222: 699-708.
  • 2Morrison VA, Dunn DL, Manivel JC, et al. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med, 1994,97 : 14-24.
  • 3Taylor AL, Marcus R,Bradley JA. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation. Crit Rev Oncol Hematol, 2005,56 : 155-167.
  • 4Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood, 1999, 94: 2208-2216.
  • 5Loren AW, Porter DL, Stadtmauer EA, et al. Post-transplant lymphoproliferative disorder: a review. Bone Marrow Transplant, 2003,31:145-155.
  • 6Choquet S, Mamzer BM, Hermine O, et al. Identification of prognostic factors in post-transplant lymphoproliferative disorders. Recent Results Cancer Res, 2002, 159: 67-80.
  • 7Faro A. Interferon-alpha and its effects on post-transplant lymphoproliferative disorders. Springer Semin Immunophathol, 1998,20 : 425 -436.
  • 8Muti G, Cantoni S, Oreste P, et al. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment. Haematologica, 2002, 87:67-77.
  • 9Harris NL, Swerdlow SH, Frizzera G, et al. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon : IARC Press, 2001 : 264-269.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部